CDT EQUITY INC. Accounts Payable
CDT EQUITY INC. (CDT) had Accounts Payable of $3.73 million as of 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-09-08
- 2026-06-30: Accounts Payable, Current $3.73M.
- 2026-03-31: Accounts Payable, Current $2.42M.
- 2025-12-31: Accounts Payable, Current $1.91M.
- 2025-09-30: Accounts Payable, Current $613.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.73M S-1 · filed 2026-09-08 |
| 2026-03-31 | $2.42M 10-Q · filed 2026-07-15 |
| 2025-12-31 | $1.91M S-1 · filed 2026-09-08 |
| 2025-09-30 | $613.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.25M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $714.00K 10-Q/A · filed 2025-08-14 |
| 2024-12-31 | $1.43M S-1 · filed 2026-09-08 |
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.06M 10-Q/A · filed 2024-11-14 |
| 2024-03-31 | $117.00K 10-Q/A · filed 2024-11-14 |
| 2023-12-31 | $215.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $35.00K 10-Q/A · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |